This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Kei Ouchi: Innovator in Hepatitis C Research
Introduction
Kei Ouchi is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of hepatitis C research. His work focuses on developing innovative solutions to combat this viral infection, which affects millions worldwide.
Latest Patents
Kei Ouchi holds a patent for "Epitopes of hepatitis C virus." This invention provides compositions containing HCV epitopes that are recognized by cytotoxic T lymphocytes. Such polypeptides are utilized in prophylactic vaccines, immunotherapies, and assays to monitor the progress or success of immune interventions. The compositions are optimized to elicit an immune response in a genetically diverse population of individuals. He has 1 patent to his name.
Career Highlights
Ouchi is affiliated with The General Hospital Corporation, where he continues to advance his research and contribute to the medical community. His work is pivotal in the ongoing fight against hepatitis C, aiming to improve treatment outcomes for patients.
Collaborations
Throughout his career, Kei Ouchi has collaborated with notable colleagues, including Georg Lauer and Bruce D. Walker. These partnerships have enhanced the impact of his research and fostered innovation in the field.
Conclusion
Kei Ouchi's contributions to hepatitis C research exemplify the importance of innovation in medicine. His patented work and collaborations highlight his commitment to improving health outcomes for individuals affected by this virus.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile